about
Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imagingThe structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia.Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines.HPMA-copolymer conjugates targeted to tumor endothelium using synthetic oligopeptides.In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity.Polymer Cancerostatics Targeted with an Antibody Fragment Bound via a Coiled Coil Motif: In Vivo Therapeutic Efficacy against Murine BCL1 Leukemia.Passive Tumor Targeting of Polymer Therapeutics: In Vivo Imaging of Both the Polymer Carrier and the Enzymatically Cleavable Drug Model.Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles.Coiled coil peptides and polymer-peptide conjugates: synthesis, self-assembly, characterization and potential in drug delivery systemsHistidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumorsTargeted Polymer-Based Probes for Fluorescence Guided Visualization and Potential Surgery of EGFR-Positive Head-and-Neck TumorsPolymer Cancerostatics Containing Cell-Penetrating Peptides: Internalization Efficacy Depends on Peptide Type and Spacer LengthPolymer Cancerostatics Targeted by Recombinant Antibody Fragments to GD2-Positive Tumor Cells
P50
Q33651804-4DA57E99-45CB-46CA-9DC9-145DBEFD195CQ38808786-A453EF52-140D-495A-A2EA-4D601801013EQ39034610-8263F8BF-5AF0-4896-800A-6E2B366D7557Q39782523-E2763761-155A-4D84-8E0B-E91420B05BD4Q40937108-1ABB95C3-B2D6-4192-8A82-F08772E509A8Q47786062-BC535C95-71D1-4842-A0AF-BA8578340F5DQ48596332-CF7630F2-546A-4AEA-88E1-8F7DBB9B7DB4Q50223846-177E6DD9-DDDF-4096-A152-F9EC4B264F46Q87941716-91E3C1B2-95A7-4607-97B8-B7EC83F42D4DQ88578958-E8C7A649-3656-4B9A-AFE9-13BC6C2CE773Q92446249-034F47AB-81D4-4F35-8219-9525740DFA15Q92636798-3C1D3174-0639-4ADC-B5E6-20911B114EF0Q93366727-59F84240-3C67-4672-A8D0-97DB769074D2
P50
description
investigador
@es
researcher
@en
name
Robert Pola
@en
type
label
Robert Pola
@en
prefLabel
Robert Pola
@en
P31
P496
0000-0003-0025-2016